Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

medtech

  • Home
  •  
  • medtech



  • Most Read
  • Latest Comments
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US

    It’s not often thought about but as we get older, our verbal capabilities deteriorate with age and for some, this can have a drastic impact on their health when unable to communicate the state of their wellbeing. Such issues for those who are non-verbal due to neurodegenerative diseases, however, may soon be solved for those

    Read More
    Public
  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use

    It may only be a matter of time until expectant mothers can monitor the heartbeats of their unborn child from home with medtech company HeraMed (ASX: HMD) pursuing regulatory reclassification to enable their HeraBEAT device to be reinstated for commercial distribution.  HeraMED is advancing discussions with the Therapeutic Goods Administration (TGA) to reinstate its HeraBEAT

    Read More
    Public
  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors

    Meticulous gathering and analysing of data is not limited to numbers or computers alone; it has now expanded to the realm of human physiology too. Now, imagine a world where every limb movement can be measured and analysed to optimise performance, prevent injuries and enhance workplace safety.  This is the realm of dorsaVi (ASX: DVL),

    Read More
    Public
  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted

    Medical diagnostics tech company Compumedics (ASX: CMP) has seen a surge in sales with its unaudited sales data showing $49 million in revenue for FY24 which would be a new record for the Company.  Sales were driven by Compumedics’ Australian sleep and neurodiagnostic businesses which experienced significant growth, bolstered by two major Magnetoencephalography (MEG) orders

    Read More
    Public
  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays

    So you’ve seen self-driving cars and drones, now gear up for an autonomous wheelchair that dispels the need for joysticks. In wheelchair users, atrophying muscles can make it challenging to use the joystick properly, thus losing control of their wheelchair. That’s where digitising the experience further helps.  Medical device company Control Bionics (ASX: CBL)’s autonomous

    Read More
    Public
  • Singular Health launches new online DICOM viewer with ChatGPT integration
    • News

    Singular Health launches new online DICOM viewer with ChatGPT integration

    Medical technology company Singular Health Group (ASX: SHG) has publicly launched its new online DICOM (Digital Imaging and Communications in Medicine) viewer and a ChatGPT 3.5 AI integration with semi-automated patient education prompts. This enhances doctors’ analysis of medical imaging.  The product launch comes just three months after the initial online proof-of-concept. The online viewer

    Read More
    Public
  • 1
  • 2
  • 3
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.